Cargando…
Immune Disregulation in Cutaneous Squamous Cell Carcinoma of Patients with Recessive Dystrophic Epidermolysis Bullosa: A Single Pilot Study
Background: Cutaneous squamous cell carcinoma (cSCC) is one of the most devastating complications of recessive dystrophic epidermolysis bullosa (RDEB). We recently demonstrated a reduction in immune cell peritumoral infiltration in RDEB patients with cSCC, together with a reduction in CD3+, CD4+, CD...
Autores principales: | Filoni, Angela, Cicco, Gerolamo, Cazzato, Gerardo, Bosco, Anna, Lospalluti, Lucia, Tucci, Marco, Cimmino, Antonietta, Foti, Caterina, Marzullo, Andrea, Bonamonte, Domenico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877121/ https://www.ncbi.nlm.nih.gov/pubmed/35207500 http://dx.doi.org/10.3390/life12020213 |
Ejemplares similares
-
Squamous Cell Carcinoma in Patients with Inherited Epidermolysis Bullosa: Review of Current Literature
por: Bonamonte, Domenico, et al.
Publicado: (2022) -
Dystrophic Epidermolysis Bullosa
por: Yadav, Randhir Sagar, et al.
Publicado: (2018) -
Quality of Life and Economic Burden in Recessive Dystrophic Epidermolysis Bullosa
por: Jeon, In Kyung, et al.
Publicado: (2016) -
Peripheral neuro-immune pathology in recessive dystrophic epidermolysis bullosa
por: Mack, Madison, et al.
Publicado: (2014) -
Deconstructing progressive inflammatory fibrosis in recessive dystrophic epidermolysis bullosa
por: Ebens, Christen L
Publicado: (2021)